677 related articles for article (PubMed ID: 21987802)
21. Rheumatoid arthritis-associated antibodies in healthy first-degree relatives of RA patients.
Vega-Morales D; Pérez-Barbosa L; Vega-Sevilla LF; Esquivel-Valerio JA; Ramírez-Monterrubio LE; Gonzalez-Torres KI; Leal-Bramasco AS; Elizondo-Solis CV; Mendiola-Jimenez A; Garza-Elizondo MA; Galarza-Delgado DÁ
Int J Immunogenet; 2023 Feb; 50(1):19-23. PubMed ID: 36428093
[TBL] [Abstract][Full Text] [Related]
22. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
Sidiras P; Spruyt D; Gangji V; Imbault V; Sokolova T; Durez P; Communi D; Rasschaert J; Badot V
Scand J Rheumatol; 2021 Mar; 50(2):118-123. PubMed ID: 33025839
[No Abstract] [Full Text] [Related]
24. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
Elsayed SA; Esmail MA; Ali RM; Mohafez OM
Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487
[TBL] [Abstract][Full Text] [Related]
25. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
[TBL] [Abstract][Full Text] [Related]
26. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
27. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
[TBL] [Abstract][Full Text] [Related]
28. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
[TBL] [Abstract][Full Text] [Related]
29. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies.
Pratesi F; Tommasi C; Anzilotti C; Puxeddu I; Sardano E; Di Colo G; Migliorini P
Clin Exp Immunol; 2011 Jun; 164(3):337-45. PubMed ID: 21413944
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
[TBL] [Abstract][Full Text] [Related]
32. Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
Nakabo S; Yoshifuji H; Hashimoto M; Imura Y; Nakashima R; Murakami K; Kuramoto N; Ito S; Satoh J; Tanaka M; Fujii T; Mimori T; Ohmura K
J Rheumatol; 2017 Sep; 44(9):1384-1388. PubMed ID: 28507178
[TBL] [Abstract][Full Text] [Related]
33. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
[TBL] [Abstract][Full Text] [Related]
34. Relatedness of Antibodies to Peptides Containing Homocitrulline or Citrulline in Patients with Rheumatoid Arthritis.
Lac P; Racapé M; Barra L; Bell DA; Cairns E
J Rheumatol; 2018 Mar; 45(3):302-309. PubMed ID: 29196382
[TBL] [Abstract][Full Text] [Related]
35. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
Ten Brinck RM; van Steenbergen HW; van Delft MAM; Verheul MK; Toes REM; Trouw LA; van der Helm-van Mil AHM
Rheumatology (Oxford); 2017 Dec; 56(12):2145-2153. PubMed ID: 28968865
[TBL] [Abstract][Full Text] [Related]
36. Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational study.
Vega-Morales D; Garza-Elizondo MA; Trouw LA; Gonzalez-Torres KI; Torres-Lopez E; Eguia-Bernal M; Loredo-Alanis SA; Gracia-Arechiga TS; Vazquez-Fuentes BR; Castañeda-Martinez DD; Castañeda-Martinez MM; Elizondo-Solis CV; Mendiola-Jimenez A; Salinas-Carmona MC; Herrera-Sandate P; la Garza JAC; Rodriguez-Sanchez GE; Galarza-Delgado DA
Mod Rheumatol; 2022 Feb; 32(2):330-337. PubMed ID: 33853472
[TBL] [Abstract][Full Text] [Related]
37. Ureido group-specific antibodies are induced in rabbits immunized with citrulline- or homocitrulline-containing antigens.
Turunen S; Koivula MK; Risteli L; Risteli J
Autoimmunity; 2016 Nov; 49(7):459-465. PubMed ID: 27098309
[TBL] [Abstract][Full Text] [Related]
38. Breach of autoreactive B cell tolerance by post-translationally modified proteins.
Dekkers JS; Verheul MK; Stoop JN; Liu B; Ioan-Facsinay A; van Veelen PA; de Ru AH; Janssen GMC; Hegen M; Rapecki S; Huizinga TWJ; Trouw LA; Toes REM
Ann Rheum Dis; 2017 Aug; 76(8):1449-1457. PubMed ID: 28442530
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
Lamacchia C; Courvoisier DS; Jarlborg M; Bas S; Roux-Lombard P; Möller B; Ciurea A; Finckh A; Bentow C; Martinez-Prat L; Mahler M; Gabay C; Nissen MJ;
Rheumatology (Oxford); 2021 Oct; 60(10):4598-4608. PubMed ID: 33502443
[TBL] [Abstract][Full Text] [Related]
40. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH
Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
